Quince Therapeutics Inc
NASDAQ:QNCX

Watchlist Manager
Quince Therapeutics Inc Logo
Quince Therapeutics Inc
NASDAQ:QNCX
Watchlist
Price: 1.82 USD 2.25% Market Closed
Market Cap: 82.8m USD
Have any thoughts about
Quince Therapeutics Inc?
Write Note

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of QNCX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

QNCX Intrinsic Value
Not Available
Base Case Scenario
Compare QNCX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about QNCX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Quince Therapeutics Inc

Provide an overview of the primary business activities
of Quince Therapeutics Inc.

What unique competitive advantages
does Quince Therapeutics Inc hold over its rivals?

What risks and challenges
does Quince Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Quince Therapeutics Inc recently?

Show all valuation multiples
for Quince Therapeutics Inc.

Provide P/S
for Quince Therapeutics Inc.

Provide P/E
for Quince Therapeutics Inc.

Provide P/OCF
for Quince Therapeutics Inc.

Provide P/FCFE
for Quince Therapeutics Inc.

Provide P/B
for Quince Therapeutics Inc.

Provide EV/S
for Quince Therapeutics Inc.

Provide EV/GP
for Quince Therapeutics Inc.

Provide EV/EBITDA
for Quince Therapeutics Inc.

Provide EV/EBIT
for Quince Therapeutics Inc.

Provide EV/OCF
for Quince Therapeutics Inc.

Provide EV/FCFF
for Quince Therapeutics Inc.

Provide EV/IC
for Quince Therapeutics Inc.

Show me price targets
for Quince Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Quince Therapeutics Inc?

How accurate were the past Revenue estimates
for Quince Therapeutics Inc?

What are the Net Income projections
for Quince Therapeutics Inc?

How accurate were the past Net Income estimates
for Quince Therapeutics Inc?

What are the EPS projections
for Quince Therapeutics Inc?

How accurate were the past EPS estimates
for Quince Therapeutics Inc?

What are the EBIT projections
for Quince Therapeutics Inc?

How accurate were the past EBIT estimates
for Quince Therapeutics Inc?

Compare the revenue forecasts
for Quince Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Quince Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Quince Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Quince Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Quince Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Quince Therapeutics Inc with its peers.

Analyze the financial leverage
of Quince Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Quince Therapeutics Inc.

Provide ROE
for Quince Therapeutics Inc.

Provide ROA
for Quince Therapeutics Inc.

Provide ROIC
for Quince Therapeutics Inc.

Provide ROCE
for Quince Therapeutics Inc.

Provide Gross Margin
for Quince Therapeutics Inc.

Provide Operating Margin
for Quince Therapeutics Inc.

Provide Net Margin
for Quince Therapeutics Inc.

Provide FCF Margin
for Quince Therapeutics Inc.

Show all solvency ratios
for Quince Therapeutics Inc.

Provide D/E Ratio
for Quince Therapeutics Inc.

Provide D/A Ratio
for Quince Therapeutics Inc.

Provide Interest Coverage Ratio
for Quince Therapeutics Inc.

Provide Altman Z-Score Ratio
for Quince Therapeutics Inc.

Provide Quick Ratio
for Quince Therapeutics Inc.

Provide Current Ratio
for Quince Therapeutics Inc.

Provide Cash Ratio
for Quince Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Quince Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Quince Therapeutics Inc?

What is the current Free Cash Flow
of Quince Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Quince Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Quince Therapeutics Inc

Current Assets 33.8m
Cash & Short-Term Investments 31.6m
Other Current Assets 2.2m
Non-Current Assets 73.3m
Long-Term Investments 78k
PP&E 941k
Intangibles 62.4m
Other Non-Current Assets 9.9m
Current Liabilities 8.4m
Accounts Payable 3m
Accrued Liabilities 5.3m
Non-Current Liabilities 80.2m
Long-Term Debt 15.3m
Other Non-Current Liabilities 64.9m
Efficiency

Free Cash Flow Analysis
Quince Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Quince Therapeutics Inc

Revenue
0 USD
Operating Expenses
-60.9m USD
Operating Income
-60.9m USD
Other Expenses
216k USD
Net Income
-60.7m USD
Fundamental Scores

QNCX Profitability Score
Profitability Due Diligence

Quince Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
27/100
Profitability
Score

Quince Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

QNCX Solvency Score
Solvency Due Diligence

Quince Therapeutics Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
40/100
Solvency
Score

Quince Therapeutics Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QNCX Price Targets Summary
Quince Therapeutics Inc

Wall Street analysts forecast QNCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QNCX is 7.4 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

Lowest
Price Target
4.04 USD
122% Upside
Average
Price Target
7.4 USD
306% Upside
Highest
Price Target
10.5 USD
477% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Quince Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for QNCX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

QNCX Insider Trading
Buy and sell transactions by insiders